Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

被引:6
|
作者
Gu, Lili [1 ]
Ju, Yue [1 ]
Hu, Min [1 ]
Zheng, Miao [1 ]
Li, Qin [1 ]
Zhang, Xinyue [1 ]
机构
[1] Hangzhou Med Coll, Key Lab Neuropsychiat Drug Res Zhejiang Prov, Hangzhou 310013, Peoples R China
关键词
PPAR gamma; Alzheimer's disease; Cholesterol; Inflammation; ACTIVATED-RECEPTOR-GAMMA; A-BETA CLEARANCE; NF-KAPPA-B; LIPID RAFTS; INTRACEREBRAL HEMORRHAGE; HEMATOMA RESOLUTION; THERAPEUTIC TARGET; AMYLOID-BETA; IN-VITRO; EXPRESSION;
D O I
10.1007/s11011-022-01139-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxidase proliferator receptors (PPARs) are defined as key sensors and regulators of cell metabolism, transcription factors activated by ligands, involved in lipid, glucose and amino acid metabolism, participating in the processes of cell differentiation, apoptosis, inflammation regulation, and acute and chronic nerve damage. Among them, PPAR gamma is expressed in different brain regions and can regulate lipid metabolism, mitochondrial disorders, oxidative stress, and cell apoptosis. It has anti-inflammatory activity and shows neuroprotection. The regulation of A beta levels in Alzheimer's disease involves cholesterol metabolism and inflammation, so this article first analyzes the biological functions of PPAR gamma, then mainly focuses on the relationship between cholesterol and inflammation and A beta, and elaborates on the regulation of PPAR gamma on key proteins and the corresponding molecules, which provides new ideas for the treatment of AD.
引用
收藏
页码:839 / 854
页数:16
相关论文
共 50 条
  • [41] Inflammation and Alzheimer’s disease
    Young-Jung Lee
    Sang Bae Han
    Sang-Yoon Nam
    Ki-Wan Oh
    Jin Tae Hong
    Archives of Pharmacal Research, 2010, 33 : 1539 - 1556
  • [42] Inflammation in Alzheimer's Disease
    Fakhoury, Marc
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (11) : 959 - 961
  • [43] Inflammation and Alzheimer's disease
    Gupta, A
    Pansari, K
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (01) : 36 - 39
  • [44] Inflammation and Alzheimer's Disease
    Reich, Arno
    Schulz, Joerg B.
    GEROPSYCH-THE JOURNAL OF GERONTOPSYCHOLOGY AND GERIATRIC PSYCHIATRY, 2007, 20 (01) : 39 - 45
  • [45] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [46] Inflammation in Alzheimer's disease
    Akiyama, H
    BRAIN PATHOLOGY, 2000, 10 (04) : 707 - 708
  • [47] Regulation of beta-amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
    Qiu, Weimin
    Liu, Hui
    Liu, Yijun
    Lu, Xin
    Wang, Lei
    Hu, Yanyu
    Feng, Feng
    Li, Qi
    Sun, Haopeng
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (04) : 1091 - 1140
  • [48] Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease
    de Chaves, Elena Posse
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2012, 90 (06) : 753 - 764
  • [49] Research progress on the protection and mechanism of active peptides in Alzheimer's disease and Parkinson's disease
    Ding, Xuying
    Chen, Yutong
    Zhang, Xiaojun
    Duan, Yanming
    Yuan, Guojing
    Liu, Chang
    NEUROPEPTIDES, 2024, 107
  • [50] Therapeutic perspectives in Alzheimer's disease: research into slowing its progress
    Piau, A.
    Hein, C.
    Nourhashemi, F.
    Vellas, B.
    CAHIERS DE L ANNEE GERONTOLOGIQUE, 2009, 1 (01): : 15 - 25